M46.9 – Inflammatory Spondylopathy, Unspecified
M46.9 is an ICD-10 code for an inflammatory spinal disorder, unspecified. It is used when spinal inflammation is diagnosed but the exact type or cause has not yet been determined.
Things worth knowing about "M46.9"
M46.9 is an ICD-10 code for an inflammatory spinal disorder, unspecified. It is used when spinal inflammation is diagnosed but the exact type or cause has not yet been determined.
What does the ICD-10 code M46.9 mean?
The ICD-10 code M46.9 stands for inflammatory spondylopathy, unspecified. It belongs to the group of inflammatory spondylopathies (M46) and is used when inflammation of the spine has been diagnosed, but the exact type or underlying cause has not yet been fully established.
Causes
Inflammatory spinal disorders can have a variety of causes, including:
- Autoimmune conditions: Such as ankylosing spondylitis (Bechterew's disease), where the immune system attacks the spinal joints.
- Infectious causes: Bacterial or viral infections that spread to spinal structures, such as spondylodiscitis.
- Reactive arthritis: Inflammation triggered by an infection elsewhere in the body.
- Psoriatic spondyloarthropathy: Spinal inflammation associated with psoriasis.
- Idiopathic causes: Cases in which no clear underlying cause can be identified.
Symptoms
Symptoms of an inflammatory spinal disorder can vary but commonly include:
- Chronic back pain, often worse in the morning (known as inflammatory back pain)
- Morning stiffness of the spine that improves with movement
- Reduced spinal mobility and range of motion
- General malaise, fatigue, and elevated body temperature (in cases of infectious origin)
- Radiating pain into the buttocks, hips, or legs
- Tenderness over the affected vertebrae
Diagnosis
Since M46.9 is an unspecified code, it is frequently used as a preliminary diagnosis until further investigation allows for more precise classification. Common diagnostic approaches include:
- Blood tests: Inflammatory markers such as CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate); HLA-B27 antigen testing when ankylosing spondylitis is suspected.
- Imaging: X-rays of the spine; MRI (magnetic resonance imaging) for early detection of inflammatory changes.
- Bone scintigraphy: When infectious or inflammatory foci are suspected.
- Biopsy: In selected cases for pathogen identification or histological examination.
Treatment
Treatment depends on the underlying cause. General therapeutic approaches include:
Medication
- NSAIDs (non-steroidal anti-inflammatory drugs): To reduce pain and inflammation, such as ibuprofen or diclofenac.
- Corticosteroids: For severe inflammatory flares.
- Biologics (TNF inhibitors): For autoimmune forms such as ankylosing spondylitis.
- Antibiotics: In cases of infectious spondylodiscitis.
Non-pharmacological therapy
- Physiotherapy and exercise therapy: To maintain and improve spinal mobility.
- Heat applications: To relieve stiffness and pain.
- Occupational therapy: To adapt daily activities to functional limitations.
Surgical therapy
In severe cases, such as spinal instability or neurological deficits, surgical intervention may be required.
Related ICD-10 codes within M46
Within the M46 group, more specific codes exist:
- M46.0 – Spinal enthesopathy
- M46.1 – Sacroiliitis, not elsewhere classified
- M46.2 – Osteomyelitis of the vertebra
- M46.3 – Infection of intervertebral disc (pyogenic)
- M46.4 – Discitis, unspecified
- M46.5 – Other infective spondylopathies
- M46.8 – Other specified inflammatory spondylopathies
- M46.9 – Inflammatory spondylopathy, unspecified
References
- World Health Organization (WHO): International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: WHO Press.
- Braun J., Sieper J.: Ankylosing Spondylitis. The Lancet, 369(9570), 1379–1390 (2007). DOI: 10.1016/S0140-6736(07)60635-7.
- Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM): ICD-10-GM 2024 – Systematisches Verzeichnis. Available at: https://www.bfarm.de
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.